| TAC04283 |
PHI-101 |
|
98%+ |
| TAC04284 |
PHI-501 |
|
98%+ |
| TAC04277 |
RO7117418 |
|
98%+ |
| TAC04276 |
RO7119929 |
|
98%+ |
| TAC04300 |
RXC004 |
|
98%+ |
| TAC00119 |
sgd-1882 |
SGD-1882 is a cytotoxic, DNA minor-groove crosslinking agent pyrrolobenzodiazepine (PBD) dimer, acting as the payload for ADCs. |
98%+ |
| TAC04275 |
SOP1812（QN-302） |
|
98%+ |
| TAC04296 |
SP-3164 |
|
98%+ |
| TAC04278 |
STAT3-IN-7 |
|
98%+ |
| TAC04301 |
TAS2940 |
|
98%+ |
| TAC04281 |
Tinengotinib (TT-00420) |
|
|
| TAC04305 |
TNG908 |
|
98%+ |
| TAC04306 |
VIC-1911 (TAS-119) |
|
98%+ |
| TAC04304 |
YAP-TEAD-IN-3(IAG933) |
YAP-TEAD-IN-3 (compound 155) is a YAP/TAZ-TEAD inhibitor. YAP-TEAD-IN-3 inhibits Avi-humanTEAD4217-434 with an IC50 value of 9 nM. YAP-TEAD-IN-3 also inhibits NCI-H2052 with an GI50 of 0.048 μM (cell proliferation)，and an IC50 of 0.048 μM (YAP reporter gene expression)，respsectively[1]. |
98%+ |
